What the midterms mean for marijuana policy, from Texas to the statehouses most likely to act
Texas, North Carolina and Mississippi elected Democratic senators on Nov. 3, but cannabis law is made in statehouses, where Texas changed most, North Carolina enough to pass medical cannabis, and Mississippi barely. The likeliest 2027 legalizers are Pennsylvania and Wisconsin, where Democrats now control all of state government.
AP called Texas's races for James Talarico (D) over Ken Paxton (R) for Senate, 55.1%–43.0%; Gina Hinojosa (D) over Greg Abbott (R) for governor, 52.8%–45.7%; and Vikki Goodwin (D) over Dan Patrick (R) for lieutenant governor, 51.7%–45.6%. It called North Carolina's Senate race for Roy Cooper (D) over Michael Whatley (R), 58.8%–39.1%, and Mississippi's for Scott Colom (D) over Cindy Hyde-Smith (R), 49.4%–48.5%. Counts are AP's as of Nov. 11–17 and may have changed; legislative results are unofficial until certified.
Texas: the biggest swing, but the hard part is the Senate
Democrats won Texas's statewide offices and House; Republicans kept the Senate (Texas Public Radio). Patrick, who dared voters to remove him over legalization (Texas Tribune), lost, so the Senate's agenda-setter is now pro-reform.
Prefiled 2027 bills HB 369 (Rep. Joe Moody) and HB 362 (Rep. John Bucy III) would legalize up to 2 ounces for adults 21 and older, 12 home plants and licensed retail, with no local bans; SB 237 (Sen. Carol Alvarado) allows 2.5 ounces, a county opt-out and no new excise taxes (Marijuana Moment). Hinojosa's proposed referendum would require a constitutional amendment passing both chambers by two-thirds, so Senate Republicans keep a say.
Hemp likely comes first. After Abbott vetoed Patrick's hemp-THC ban, agency rules effectively banned many products and now face court challenges; Goodwin wants state health officials to unwind them, and Hinojosa ran on a THC vote (ABC13). Houston voters approved Proposition A, making misdemeanor possession the lowest police priority (NORML), and about 80% of March Democratic primary voters backed nonbinding legalization.
Bottom line: Expect hemp-rule rollbacks, a regulated THC market and decriminalization in 2027; adult-use needs Republican votes for an amendment. Smokable products may still need a federal rollback or a state-built market (Texas Tribune).
North Carolina: medical cannabis's best shot in a decade
Medical cannabis cleared the Republican Senate in 2022, 2023 and 2024, but former Speaker Tim Moore never gave it a House floor vote (MPP). Democrats now hold 71 of 120 House seats, ending 16 years of GOP control (Nelson Mullins, WSOC). Republicans appear to keep the Senate 26-24, with one race within a few hundred votes, but lost their veto-proof supermajority (Axios Raleigh). Gov. Josh Stein (D) backs legalization; his advisory council, which recommended an adult-use market with medical-patient protections over a medical-only program, is briefing lawmakers (Cannabis Business Times).
Incoming Speaker Robert Reives (D) calls decriminalization top of mind and backs medical cannabis for veterans (Marijuana Moment). The House shelved HB 328, a near-ban capping hemp at 0.4 mg of THC, until after the election rather than upset a $3–4 billion, 16,000-job industry (Cardinal & Pine); a new majority could rewrite it as regulation.
Bottom line: North Carolina is the likeliest of the three to act in 2027, probably pairing medical cannabis (already passed by Senate Republicans like Sen. Bill Rabon) with hemp regulation and possibly decriminalization. Adult-use needs the GOP Senate.
Mississippi: a federal flip, not a state one
Gov. Tate Reeves (R) stays, and the Legislature wasn't up. In March he vetoed both medical cannabis bills despite veto-proof support, and an override failed (MPP, NORML). Voters can't bypass him: the state Supreme Court voided the initiative process in 2021 by striking down the voter-approved medical program, and a February restoration effort died in the Senate (Magnolia Tribune). Adult-use isn't in play; medical fixes and civil first-offense possession are.
Bottom line: Colom's seat matters for federal banking and rescheduling votes, not state law; the next opening is the 2027 state elections.
Who actually moves first
Legalization comes first where the election removed the last veto point. In Pennsylvania, Democrats flipped the Senate, completing a trifecta with pro-legalization Gov. Josh Shapiro; becoming the 25th adult-use state is realistic in 2027 (Cannabis Business Times). In Wisconsin, Democrats won their first trifecta in 16 years, incoming Gov. David Crowley backs legalization (NORML), and with no medical program, one bill could create both. North Carolina, Texas and Mississippi follow. Virginia opens the region's next market: applications in February, sales July 1, 2027 (NC Newsline).
The federal picture: rescheduled, but not settled
On April 23, the Justice Department moved state-licensed medical marijuana and FDA-approved products to Schedule III; adult-use awaits the outcome of a DEA hearing held June 29–July 15 (American Bar Association). Medical licensees escape Section 280E (NORML). Hemp is moving the other way: a ban on synthetic cannabinoids such as THC-O took effect Nov. 12, and a 0.4 mg-per-container total-THC cap, covering delta-8, arrives Dec. 11 unless Congress acts (Akerman).
AP's Nov. 17 count gives Democrats 55 Senate seats, Republicans 44 and one seat no party; control is inferred from counts, not an AP call. The Cannabis Administration and Opportunity Act (Sens. Schumer, Booker and Wyden) is the likely vehicle, and SAFE Banking returned in June (Harris Sliwoski). Yet SAFER Banking sat 15 months after 2023 committee approval without a floor vote (Cannabis Business Times), and legalization faces the filibuster and a possible veto. Banking reform and a hemp-deadline fix are realistic; descheduling is a long shot.
The overarching movement
Reform is shifting from ballot box to statehouse, and toward the South and Midwest. This year's statewide measures sought only rollbacks, and failed: AP called Massachusetts Question 8 for "No" (75.6%), keeping adult-use, and Idaho HJR 4 for "No" (66.3%), preserving drug-policy initiatives. Most holdouts lack citizen initiatives, so legislatures must act (ArentFox Schiff).
Hemp is the wedge: gas-station THC forced action in Texas and North Carolina, and the federal cap will push hemp-heavy states toward "regulate all THC" bills. The South goes medical first, then decriminalization, with Schedule III giving cautious Republicans cover. And Massachusetts shows voters protect existing markets.
The midterms legalized cannabis nowhere; they changed the conditions for deciding (Marijuana Moment). The 2027 sessions will show what that is worth.
This article was written by David Feldman and Magnolia Mullen.